Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

SAE Media Group

  1. Events
  2. Organisers
  3. SAE Media Group
Events from this organiser
Today

Injectable Drug Delivery Conference

The SAE Injectable Drug Delivery Conference returns in 2025, serving as a specialised forum for senior technical professionals from leading pharmaceutical companies to explore the [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top